Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with s
Author: ["Peggy L. Porter","Kathleen E. Malone","Patrick J. Heagerty","Gail M. Alexander","Laura A. Gatti","Eduardo J. Firpo","Janet R. Daling","James M. Roberts"]
Publication: Nature Medicine
CITE.CC academic search helps you expand the influence of your papers.
Abstract
Mutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently found in human cancers1. However, tumor-specific mutations are uncommon in genes encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also thought to contribute to tumor progression2–8. It is now known that levels of both cyclin E and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of these proteins can be altered by means other than simply mutation of their respective genes9,10. Thus, changes in p27 and cyclin E protein levels in tumors might be more common than previously anticipated and may be indicators of tumor behavior.
Cite this article
Porter, P., Malone, K., Heagerty, P. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3, 222–225 (1997). https://doi.org/10.1038/nm0297-222
